Evolutionary medicine and chronic inflammatory state - Known and new concepts in pathophysiology

Journal of Molecular Medicine

Volumn 90, Issue 5, 2012, Pages 523-534

  Straub, Rainer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Autoimmunity; Hormone; System biology

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA B27 ANTIGEN; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADAPTIVE IMMUNITY; ANEMIA; ANKYLOSING SPONDYLITIS; ANOREXIA; B LYMPHOCYTE; CACHEXIA; CELL MATURATION; CHRONIC INFLAMMATION; CIRCADIAN RHYTHM; CONCEPTUAL FRAMEWORK; CROHN DISEASE; DENGUE; DEPRESSION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENERGY METABOLISM; EVOLUTION; FATIGUE; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMMUNOREGULATION; INFECTION RISK; INSULIN RESISTANCE; MALNUTRITION; MOLECULAR PATHOLOGY; MUSCLE ATROPHY; NATURAL SELECTION; NONHUMAN; OBESITY; OSTEOPENIA; PLEIOTROPY; POSITIVE SELECTION; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; WATER LOSS;

ANIMALS; BIOLOGICAL EVOLUTION; CHRONIC DISEASE; ENERGY METABOLISM; HUMANS; INFLAMMATION; MEDICINE; MODELS, BIOLOGICAL;

EID: 84862585967     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0861-8     Document Type: Review

References (67)

1. Ramsey SA, Gold ES, Aderem A (2010) A systems biology approach to understanding atherosclerosis. EMBO Mol Med 2:79-89
2. Karp PD (2001) Pathway databases: a case study in computational symbolic theory. Science 293:2040-2044
3. Meyer-Hermann M, Figge MT, Toellner KM (2009) Germinal centres seen through the mathematical eye: B-cell models on the catwalk. Trends Immunol 30:157-164
4. Besedovsky HO, Del Rey A (1996) Immune-neuro-endocrine interactions. Endocr Rev 17:64-102
5. Nesse RM (2001) How is Darwinian medicine useful? West J Med 174:358-360
6. Nesse RM (2000) Is depression an adaptation? Arch Gen Psychiatry 57:14-20
7. Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:398-411
8. Straub RH, Besedovsky HO (2003) Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 17:2176-2183
9. Straub RH, Cutolo M, Buttgereit F, Pongratz G (2010) Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 267:543-560
10. Straub RH (2011) Concepts of evolutionary medicine and energy regulation contribute to the etiology of systemic chronic inflammatory diseases. Brain Behav Immun 25:1-5
11. Rolfe DF, Brown GC (1997) Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77:731-758
12. Blaxter K(1989) Energymetabolismin animals andman. Cambridge University Press, Cambridge
13. Le Magnen J (1988) Lipogenesis, lipolysis and feeding rhythms. Ann Endocrinol (Paris) 49:98-104
14. Lange T, Dimitrov S, Fehm HL,Westermann J, Born J (2006) Shift of monocyte function toward cellular immunity during sleep. Arch Intern Med 166:1695-1700
15. Lange T, Dimitrov S, Bollinger T, Diekelmann S, Born J (2011) Sleep after vaccination boosts immunological memory. J Immunol 187:283-290
16. Ostensen M, Almberg K, Koksvik HS (2000) Sex, reproduction, and gynecological disease in young adults with a history of juvenile chronic arthritis. J Rheumatol 27:1783-1787
17. Silva CA et al (2010) Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol Int 31(8):1037-1043
18. Villiger PM, Caliezi G, Cottin V, Forger F, Senn A, Ostensen M (2010) Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 69:1842-1844
19. Soares PM, Borba EF, Bonfa E, Hallak J, Correa AL, Silva CA (2007) Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 56:2352-2361
20. Suehiro RM, Borba EF, Bonfa E, Okay TS, Cocuzza M, Soares PM, Silva CA (2008) Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology (Oxford) 47:1692-1697
21. LaFleur C et al (2002) HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol 63:1039-1044
22. Meyer-Hermann ME, Maini PK (2005) Cutting edge: back to "one-way" germinal centers. J Immunol 174:2489-2493
23. Meyer-Hermann M (2002) A mathematical model for the germinal center morphology and affinity maturation. J Theor Biol 216:273-300
24. Murphy KM, Travers P,WalportM(2011) Janeway's immunobiology. Taylor & Francis, Oxford
25. Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25:154-159
26. Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153-160
27. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46-56
28. Davies JW, Lamke LO, Liljedahl SO (1974) A guide to the rate of non-renal water loss from patients with burns. Br J Plast Surg 27:325-329
29. Jacob M, Chappell D, Hofmann-Kiefer K, Conzen P, Peter K, Rehm M (2007) Determinants of insensible fluid loss. Perspiration, protein shift and endothelial glycocalyx. Anaesthesist 56:747-758, 760-764
30. Berg JM, Tymoczko JL, Stryer L (2002) Biochemistry. Freeman, New York
31. Michal G (1999) Biochemical pathways. Spektrum Akademischer Verlag, Heidelberg
32. Rassow J, Hauser K, Netzker R, Deutzmann R (2008) Biochemistry. Georg Thieme, Stuttgart
33. Tredget EE, Yu YM (1992) The metabolic effects of thermal injury. World J Surg 16:68-79
34. Bader M, Ganten D (2000) Regulation of renin: new evidence from cultured cells and genetically modified mice. J Mol Med (Berl) 78:130-139
35. Hattangady N, Olala L, Bollag WB, Rainey WE (2011) Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol. doi:10.1016/j.mce. 2011.07.034
36. Selye H (1951) The general adaptation syndrome and the diseases of adaptation. Am J Med 10:549-555
37. Dorffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR, Scholze J (1999) Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 34:113-117
38. Phillips MI, Kagiyama S (2002) Angiotensin II as a proinflammatory mediator. Curr Opin Investig Drugs 3:569-577
39. Boos CJ, Lip GY (2006) Is hypertension an inflammatory process? Curr Pharm Des 12:1623-1635
40. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A (2005) Human immunosenescence: is it infectious? Immunol Rev 205:257-268, 257-268
41. Straub RH, Cutolo M, Zietz B, Schölmerich J (2001) The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 122:1591-1611
42. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP (1997) Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66:54-62
43. Tsigos C, Papanicolaou DA, Kyrou I, Raptis SA, Chrousos GP (1999) Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis. J Interferon Cytokine Res 19:1271-1276
44. Kirkwood TB, Austad SN (2000) Why do we age? Nature 408:233-238
45. Straub RH, Del Rey A, Besedovsky HO (2007) Emerging concepts for the pathogenesis of chronic disabling inflammatory diseases: neuroendocrine-immune interactions and evolutionary biology. In: Ader R (ed) Psychoneuroimmunology. Elsevier, San Diego, pp 217-232
46. Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63-70
47. Jessop DS, Harbuz MS (2005) A defect in cortisol production in rheumatoid arthritis: why are we still looking? Rheumatology (Oxford) 44:1097-1100
48. Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo- Repo M (2002) Inadequately low serum levels of steroid hormones in relation to IL-6 and TNF in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 46:654-662
49. Yasuda M, Yasuda D, Tomooka K, Nobunaga M (1993) Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases. Clin Rheumatol 12:231-235
50. Straub RH, Hall C, Kramer BK, Elbracht R, Palitzsch KD, Lang B, Schölmerich J (1996) Atrial natriuretic factor and digoxin-like immunoreactive factor in diabetic patients: their interrelation and the influence of the autonomic nervous system. J Clin Endocrinol Metab 81:3385-3389
51. Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N, Nurmohamed MT (2010) Tumour necrosis factor alpha blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Ann Rheum Dis 69:1281-1285
52. Provan S, Angel K, Semb AG, Atar D, Kvien TK (2010) NTproBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study. Ann Rheum Dis 69:1946-1950
53. Iemitsu M, Itoh M, Fujimoto T, Tashiro M, Nagatomi R, Ohmori H, Ishii K (2000) Whole-body energy mapping under physical exercise using positron emission tomography. Med Sci Sports Exerc 32:2067-2070
54. Calder PC (1995) Fuel utilization by cells of the immune system. Proc Nutr Soc 54:65-82
55. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC (2008) Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84:949-957
56. Frauwirth KA, Thompson CB (2004) Regulation of T lymphocyte metabolism. J Immunol 172:4661-4665
57. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, Hegarty J, Lawlor E, Kelleher D (2004) Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40:108-114
58. Goulder PJ, Watkins DI (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8:619-630
59. Pertovaara M, Raitala A, Juonala M, Kahonen M, Lehtimaki T, Viikari JS, Raitakari OT, Hurme M (2007) Autoimmunity and atherosclerosis: functional polymorphism of PTPN22 is associated with phenotypes related to the risk of atherosclerosis. The Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 147:265-269
60. Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, O'Brien SJ, Astemborski J, Thomas DL (2004) Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol 78:11258-11262
61. Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M (2007) Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms. Mol Immunol 44:1011-1014
62. Gu CC et al (2007) An investigation of genome-wide associations of hypertension with microsatellite markers in the family blood pressure program (FBPP). Hum Genet 121:577-590
63. Ammendola M, Bottini N, Pietropolli A, Saccucci P, Gloria-Bottini F (2008) Association between PTPN22 and endometriosis. Fertil Steril 89:993-994
64. Miller LE, Jüsten HP, Schölmerich J, Straub RH (2000) The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 14:2097-2107
65. Straub RH, Lowin T, Klatt S, Wolff C, Rauch L (2011) Increased density of sympathetic nerve fibers in metabolically activated fat tissue surrounding human synovium and mouse lymph nodes in arthritis. Arthritis Rheum 63:3234-3242
66. Power ML, Schulkin J (2009) The evolution of obesity. The Johns Hopkins University Press, Baltimore
67. Buttgereit F, Burmester GR, Brand MD (2000) Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today 21:192-199